Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 September 2021 | Story Michelle Nöthling | Photo Supplied
Emily Matabane.

“I love teaching hearing people Sign Language,” Emily immediately mentions when asked about herself, “so that they can communicate with Deaf people and work with them.” Part of her passion, though, was borne from personal hardship. Emily had a difficult experience when she entered the work environment in 2000, since she was the only Deaf person among an all-hearing staff. Can one even begin to imagine the frustration and isolation she must have experienced? It is no wonder, then, that her vision is for Deaf people to have equal access to information, and for the hearing and Deaf to be able to communicate with each other more freely. And the latter she is pursuing with all her energy.

“When I started working as a Teaching Assistant in the UFS Department of South African Sign Language (SASL) and Deaf Studies,” Emily recalls, “few students were interested in studying Sign Language, because they were not aware of Deaf people and Sign Language.” This has started to change, though, as Emily is noticing a drastic increase in the number of UFS students enrolling for SASL. “I am now familiar with a lot of hearing student who have done Sign Language at our university, and they are very friendly when I meet them. Also, because they are able to greet me in Sign Language!” It is important to note that the department teaches SASL modules to both Deaf and hearing students (and staff) who want to learn the language – which is now also available as an online option.

As a second-year student studying BEd, Emily has formed a close relationship with CUADS (Centre for Universal Access and Disability Support) at the UFS. “CUADS is doing a great job in assisting students with disabilities and catering for their needs. They assist students to have access to education on the same level as other students without disabilities.”

Sign Language is of vital importance to the Deaf community, since it is the language of accessibility for Deaf people. “We are proud and acknowledge Sign Language as a medium of communication,” says Emily. “It allows us to express ourselves, and to teach and transfer our Deaf culture from one generation to the other.”

Ultimately, Emily is hopeful that Sign Language will become embraced, celebrated, and recognised as equal to the other official languages in South Africa.

News Archive

Link between champagne bubbles and the UFS?
2012-11-16

Prof. Lodewyk Kock with an example of a front page of the publication FEMS Yeast Research, as adapted by F. Belliard, FEMS Central Office.
Photo: Leatitia Pienaar
15 November 2012

What is the link between the bubbles in champagne and breakthrough research being done at the Mayo Clinic in America? Nano research being done at our university.

Prof. Lodewyk Kock of Biotechnology says a human being consists of millions of minute cells that are invisible to the eye. The nano technology team at the UFS have developed a technique that allows researchers to look into such a cell, as well as other microorganisms. In this way, they can get an idea of what the cell’s “insides” look like.

The UFS team – consisting of Profs. Kock, Hendrik Swart (Physics), Pieter van Wyk (Centre for Microscopy), as well as Dr Chantel Swart (Biotechnology), Dr Carlien Pohl (Biotechnology) and Liza Coetsee (Physics) – were amazed to see that the inside of cells consist of a maze of small tunnels or blisters. Each tunnel is about 100 and more nanometres in diameter – about one ten thousandth of a millimetre – that weaves through the cells in a maze.

It was also found that these tunnels are the “lungs” of the cells. Academics doing research on yeast have had to sit up and take notice of the research being done at the UFS – to the extent that these “lungs” will appear on the front page of the highly acclaimed FEMS Yeast Research for all of 2013.

The Mayo Clinic, in particular, now wants to work with the UFS to study cancer cells in more detail in order to fight this disease, says Prof. Kock. The National Cancer Institute of America has also shown interest. This new nano technology for biology can assist in the study and development of nano medicine that can be used in the treatment of cancer and other life threatening diseases. Nano medicine uses nano metal participles that are up to one billionth of a metre in size.

Prof. Kock says laboratory tests indicate that nano medicine can improve the efficacy of anti-cancer medicine, which makes the treatment less toxic. “According to the Mayo Clinic team, nano particles are considered as a gold cartridge which is being fired directly at a cancer tumour. This is compared to fine shot that spreads through the body and also attacks healthy cells.”

“This accuracy implies that the chemotherapy dose can be lowered with fewer side effects. The Mayo Clinic found that one-tenth of the normal dosage is more effective against pancreas cancer in this way than the full dosage with a linkage to nano particles. According to the clinic, this nano medicine could also delay the spread of cancer,” says Prof. Kock.

The nano particles are used as messengers that convey anti-cancer treatment to cancer cells, where it then selectively kills the cancer cells. The transport and transfer of these medicines with regard to gold nano particles can be traced with the UFS’s nano technology to collect more information, especially where it works on the cell.

“With the new nano technology of the UFS, it is possible to do nano surgery on the cells by slicing the cells in nanometre thin slices while the working of the nano medicine is studied. In this way, it can be established if the nano medicine penetrates the cells or if it is only associated with the tiny tunnels,” says Prof. Kock.

And in champagne the small “lungs” are responsible for the bubbles. The same applies to beer and with this discovery a whole new reach field opens for scientists.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept